12 June 2020 : Original article
Heart Transplant Using Hepatitis C-Seropositive and Viremic Organs in Seronegative Recipients
Yuanjia Zhu ABCDEF 1, Yasuhiro Shudo ADEF 1, Roy Lee DEF 2,3, Y. Joseph Woo ADEFG 1*DOI: 10.12659/AOT.922723
Ann Transplant 2020; 25:e922723
Supplementary Table 3 Postoperative seropositivity.
| Patient | Genotype | Immediate postoperative HCV RNA | Week 2 HCV RNA | Week 8 HCV RNA | Week 12 HCV RNA | Month 6 HCV RNA | Month 12 HCV RNA |
|---|---|---|---|---|---|---|---|
| 1 | – | – | – | – | – | – | – |
| 2 | – | – | – | – | – | – | – |
| 3 | – | – | – | – | – | – | – |
| 4 | 1B | – | – | – | 11,000 (IU/mL) | – | 4,600,000 (IU/ml) |
| 5 | – | – | – | – | – | – | – |
| 6 | – | – | – | – | – | – | – |
| 7 | 1A | 604 (IU/mL) | 191,078 (IU/mL) | Undetected | Undetected | Undetected | Undetected |
| 8 | 1A | 4774 (IU/mL) | Undetected | Undetected | Undetected | Undetected | Undetected |
| 9* | – | – | Undetected | – | Undetected | Undetected | – |
| 10 | 1A | 8,028,535 (IU/mL) | Undetected | Undetected | – | – | |
| RNA – ribonucleic acid. * Patient 9 was recommended to be tested for HCV RNA at 3, 6 and 12 months postoperatively. | |||||||